½ÃÀ庸°í¼­
»óǰÄÚµå
1736693

¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå ±Ô¸ð : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ª ¹üÀ§º° ¹× ¿¹Ãø

Global Ultrasound Gels Market Size By Type (Sterile, Non-sterile), By End-User (Clinics, Hospital, Diagnostic Centers), By Geographic Scope And Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÃÊÀ½ÆÄ °Ö ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

ÃÊÀ½ÆÄ °Ö ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 8,913¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2026-2032³â CAGR 2.80%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2032³â¿¡´Â 1¾ï 1,117¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÃÊÀ½ÆÄ °ÖÀÇ Àúºñ¿ë, »ç¿ë ¿ëÀ̼º, º´¿ø, Ŭ¸®´Ð, Áø´Ü¼¾ÅÍ¿¡¼­ ÃÊÀ½ÆÄ °Ö ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ °³¹ßµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áúº´ÀÇ Áø´Ü°ú Áúº´°ú °ü·ÃµÈ ÇÕº´ÁõÀÇ È®Àο¡ ÃÊÀ½ÆÄ¸¦ »ç¿ëÇÏ°Ô µÈ °Íµµ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå º¸°í¼­´Â ½ÃÀåÀÇ Àü¹ÝÀûÀÎ Æò°¡¸¦ ¼³¸íÇÕ´Ï´Ù. ÁÖ¿ä ºÎ¹®, µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ, ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¿äÀÎ µîÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®Çß½À´Ï´Ù.

¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÃÊÀ½ÆÄ °Ö ½ÃÀå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´ÙÀ½ÀÌ Æ÷ÇԵ˴ϴÙ.

¸¸¼º ÁúȯÀÇ ¸¸¿¬ : ¾Ï, ±Ù°ñ°Ý°è Àå¾Ö, ½ÉÇ÷°ü Àå¾Ö µîÀÇ ¸¸¼º ÁúȯÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó ÃÊÀ½ÆÄ °Ë»ç¿Í °°Àº ¿µ»ó Áø´Ü °Ë»çÀÇ Çʿ伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °ÖÀº Á¤È®ÇÑ Áø´Ü°ú ¶Ù¾î³­ À̹Ì¡À» °¡´ÉÇÏ°Ô Çϱ⠶§¹®¿¡ »ê¾÷ ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù.

ÀÇ·á ºÎ¹®ÀÇ ±Þ¼ºÀå : ÀÇ·á ¿µ»ó ¼­ºñ½ºÀÇ Çʿ伺Àº µµ½ÃÈ­, ³ë·ÉÈ­, Àα¸ Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ´Â ÀÇ·á ºÎ¹®ÀÇ ±Þ¼ÓÇÑ È®´ë·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °ÖÀÇ ¿ä±¸´Â Ŭ¸®´Ð, º´¿ø, Áø´Ü¼¾ÅÍ, ¿Ü·¡ Áø·á ½Ã¼³ µî ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼­ ÃÊÀ½ÆÄ °Ë»ç°¡ ³Î¸® »ç¿ëµÇ°í ÀÖ´Ù´Â °ÍÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÃÊÀ½ÆÄ ±â¼ú °³¹ß : ÃÊÀ½ÆÄ ÀÛµ¿ ¼ö¿ä´Â ÈÞ´ë¿ë Àåºñ, °íÇØ»óµµ À̹Ì¡ ½Ã½ºÅÛ, 3D/4D À̹Ì¡ ±â´É °³¹ß µî ÃÊÀ½ÆÄ ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¹ß¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. °íǰÁú ÃÊÀ½ÆÄ °ÖÀº À̹ÌÁö ǰÁúÀ» ±Ø´ëÈ­Çϰí Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ã۱â À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀû °³¼±¿¡ ºñÃß¾î ÇÊ¿äÇÕ´Ï´Ù.

Æ÷ÀÎÆ® ¿Àºê Äɾî ÃÊÀ½ÆÄ(POCUS) ±â¼úÀÇ »ç¿ë Áõ°¡ : ÃÊÀ½ÆÄ °Ö¿¡ ´ëÇÑ ¿ä±¸´Â ±Ù°ñ°Ý°è À̹Ì¡, ÀÀ±Þ ÀÇ·á, ±¸¸í ÀÀ±Þ, »ê°ú µî ¸¹Àº ÀÇ·á Àü¹® ºÎ¹®¿¡¼­ Æ÷ÀÎÆ® ¿Àºê Äɾî ÃÊÀ½ÆÄ(POCUS)ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖÀ½À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. POCUS Ä¡·á Áß ºü¸£°í Á¤È®ÇÑ ¿µ»ó Áø´ÜÀ» À§Çؼ­´Â ÈÞ´ë °¡´ÉÇÏ°í Æí¸®ÇÑ ÃÊÀ½ÆÄ °ÖÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¿©¼º °Ç°­ÀÇ ¿ëµµ È®´ë : ÃÊÀ½ÆÄ °Ë»ç´Â »ê°ú, ºÎÀΰú, À¯¹æ ¿µ»ó Áø´Ü°ú °°Àº ¿©¼º °Ç°­°ú °ü·ÃµÈ ¿µ»ó Áø´Ü ºÎ¹®¿¡¼­ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ¿©¼º ÀÇ·á ÇöÀå¿¡¼­ ÃÊÀ½ÆÄ °ÖÀÇ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀº ÀÓ»êºÎ Äɾî, ºÎÀΰú ÁúȯÀÇ Á¶±â ¹ß°ß, À¯¹æ¾Ï °ËÁøÀÌ Áß½ÃµÇ°Ô µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù.

°Ö Á¦ÇüÀÇ ±â¼úÀû Áøº¸: »ý»êÀÚ´Â Áö¼ÓÀûÀ¸·Î Àüµµ¼º Çâ»ó, Á¤±Õ¼º, Àú¾Ë·¹¸£±â¼º µîÀÇ Æ¯¼ºÀ» Æ÷ÇÔÇÏ¿© »õ·Ó°í °³¼±µÈ ÃÊÀ½ÆÄ °Ö Á¦ÇüÀ» ¹ßÇ¥Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ÃÊÀ½ÆÄ À̹Ì¡ÀÇ Ç°ÁúÀ» Çâ»ó½Ã۰í ÇǺΠÀÚ±ØÀÇ °¡´É¼ºÀ» ÁÙÀ̸ç ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù.

ȯÀÚÀÇ ¾ÈÀü ¹× °¨¿° °ü¸®ÀÇ Á߿伺 Áõ°¡ : COVID-19ÀÇ À¯ÇàÀ¸·Î ÀÇ·á ½Ã¼³Àº ȯÀÚÀÇ ¾ÈÀü°ú °¨¿° °ü¸®¿¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ÀÇ·á±â±âÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ´Â ¹«±Õ ÃÊÀ½ÆÄ °Ö¿¡ ´ëÇÑ °­ÇÑ ¼ö¿ä°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºñħ½ÀÀû Áø´Ü ±â¼ú¿¡ ´ëÇÑ ¼±È£ Áõ°¡ : ºñħ½ÀÀû Áø´Ü ±â¼úÀº ¾ÈÀüÇÏ°í Æí¸®ÇÏ¸ç °æÁ¦ÀûÀ̱⠶§¹®¿¡, ȯÀÚµµ °Ç°­ Àü¹®°¡µµ Á¡Á¡ ±×°ÍÀ» ¼±ÅÃÇÏ°Ô µÇ¾î ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °ÖÀÇ ¼ö¿ä´Â ±× ºñħ½ÀÀûÀÎ ¼ºÁú°ú Àü¸® ¹æ»ç¼±ÀÇ °á¿©¿¡ ÀÇÇØ ÃÊÀ½ÆÄ È­»ó Áø´ÜÀÌ È­»ó Áø´Ü¿¡ ¼±È£µÇ´Â ¸ð´Þ¸®Æ¼¶ó´Â »ç½ÇÀÌ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

³ëÀÎ Áõ°¡ : ³ëÀÎÀÌ µÇ¸é ³ëÈ­¿Í °ü·ÃµÈ Áúº´°ú ¸¸¼º Áúȯ¿¡ °É¸®±â ½¬¿öÁ® ¿µ»ó Áø´Ü ¼­ºñ½º°¡ ÇÊ¿äÇÕ´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç¿Í ÃÊÀ½ÆÄ °Ë»ç¿ë °ÖÀÇ ¼ö¿ä´Â ¼¼°èÀÇ °í·ÉÈ­¿Í ÇÔ²² Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÇコÄɾî ÁöÃâ Áõ°¡ : ÇコÄɾî ÀÎÇÁ¶ó °³¹ß, Á¤ºÎ º¸°Ç ÇÁ·Î±×·¥, º¸Çè Àû¿ë ¹üÀ§ È®´ë µîÀÌ ÇコÄÉ¾î ºÎ¹® ÀüüÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ö¿¡ ´ëÇÑ ¿ä±¸´Â ÀÌ ÇコÄɾî ÁöÃâÀÇ Áõ°¡¿¡ ÀÇÇØ ÀϺΠºÎÃß±â°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

ÃÊÀ½ÆÄ °Ö ½ÃÀå¿¡´Â ¸î °¡Áö ¿äÀÎÀÌ ¾ïÁ¦¿äÀÎ ¹× °úÁ¦·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ëüǰ °¡¿ë¼º : ÃÊÀ½ÆÄ °ÖÀº ÃÊÀ½ÆÄ À̹Ì¡ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµÇÁö¸¸, ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â ·Î¼Ç°ú Å©¸², ¹° ¹× »ý¸® ½Ä¿°¼ö¸¦ Æ÷ÇÔÇÑ ´ëü Ä¿ÇøµÁ¦µµ ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÚ¿øÀÌ ÇÑÁ¤µÈ ȯ°æ¿¡¼­´Â ´ëüǰÀÇ Á¸Àç·Î ÀÎÇØ ÃÊÀ½ÆÄ °ÖÀÇ »ó¾÷Àû È®´ë°¡ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.

Ư¼ö Á¦Á¦ÀÇ °íºñ¿ë : ÀÏ¹Ý °Ö¿¡ ºñÇØ ¹«±Õ °ÖÀ̳ª Àú¾Ë·¹¸£±â¼º °Ö µî Ư¼öÇÑ ÃÊÀ½ÆÄ °Ö Á¦Á¦´Â ºñ¿ëÀÌ ³ô¾ÆÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ö Á¦Á¦´Â °í°¡À̱⠶§¹®¿¡ ƯÈ÷ ÇコÄɾ ´ëÇÑ ÀÚ±ÝÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­´Â ÀÇ·á ½Ã¼³¿¡¼­ÀÇ »ç¿ëÀ» ÀÚÁ¦ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

ÇǺÎÀÇ °ú¹Î¼º ¹× ÀÚ±Ø ¹®Á¦ : ÀϺΠ»ç¶÷Àº ƯÈ÷ ¾Ë·¹¸£±â üÁúÀÇ »ç¶÷°ú ¹Î°¨ÇÑ ÇǺÎÀÇ »ç¶÷ÀÌ ÃÊÀ½ÆÄ °ÖÀ» »ç¿ëÇÒ ¶§ ÇǺΠ°ú¹ÎÁõ°ú Àڱذ¨À» °¡Áú ¼ö ÀÖ½À´Ï´Ù. ÇǺΰú¹ÎÁõ ȯÀÚ¿¡ ´ëÇØ¼­ ÀÇ·á Á¾»çÀÚ´Â Ä¿ÇøµÁ¦³ª Á¦Á¦¸¦ »ý°¢ÇÒ Çʿ䰡 ÀÖ¾î, ±âÁ¸ ÃÊÀ½ÆÄ °ÖÀÇ ½ÃÀåÀÌ Á¦ÇÑµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

±ÔÁ¦ Áؼö ¹× ǰÁú ±âÁØ : ÃÊÀ½ÆÄ °ÖÀº ÀÇ·á±â±â·Î °£ÁֵǹǷΠÁö¿ª¿¡ µû¶ó ´Ù¸¥ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ǰÁú ±âÁØÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. Á¦Á¶¾÷ÀÚ´Â ÀûÁ¤Á¦Á¶±âÁØ(GMP)À̳ª Á¦Ç° ǰÁú¿ä°Ç µîÀÇ ¹ý·üÀ» ÁؼöÇϱ⠾î·Á¿ö ½Å½ÃÀå ÁøÀÔÀ̳ª ¼ºÀå¿¡ Àå¾Ö°¡ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

º¸°ü ¹× À¯Åë±âÇÑ¿¡ °üÇÑ ¹®Á¦ : ÃÊÀ½ÆÄ °ÖÀÇ º¸°ü¿¡´Â ¿Âµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ°í ¿À¿°À» ¹æÁöÇÏ´Â µî Ưº°ÇÑ Ãë±ÞÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÃÊÀ½ÆÄ °ÖÀÇ º¸Á¸±â°£ÀÌ Âª±â ¶§¹®¿¡ ÇコÄÉ¾î ½Ã¼³¿¡¼­ Àç°í°ü¸®, Á¦Ç°ÀÇ ½Å¼±µµ, Æó±â¹° Àý°¨ Ãø¸é¿¡¼­ ¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼ºÐÈ­µÈ »ê¾÷ »óȲ : ÃÊÀ½ÆÄ °Ö »ê¾÷¿¡´Â ¸¹Àº Á¦Á¶¾÷ü, °ø±Þ¾÷ü ¹× À¯Åë¾÷ü°¡ Á¸ÀçÇϸç, ½ÃÀå »óȲÀº ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÀÔ ±â¾÷ °£ÀÇ °­ÇÑ °æÀïÀº °¡°Ý¿¡ ´ëÇÑ ¾Ð·Â, ÀÌÀÍ·ü ÀúÇÏ, Á¦Ç°ÀÇ Â÷º°È­ ÀúÇϸ¦ ÃÊ·¡ÇÒ °¡´É¼ºÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ¸ðµÎ ½ÃÀå È®´ë¿¡ ¹æÇذ¡ µË´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ : ¼¼°èÀÇ ÇコÄÉ¾î ½Ã½ºÅÛÀº COVID-19 ÆÒµ¥¹Í¿¡ Èçµé¸®°í ȯÀÚ °ü¸® ±â¼ú, ¿¹»ê ¹èºÐ, Çコ ÄɾîÀÇ ¿ì¼± ¼øÀ§¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÆÒµ¥¹Í µ¿¾È ±ä±Þ¼ºÀÌ ¾ø´Â ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü°ú °°Àº ¼±ÅÃÀû ¼ö¼ú Áß´ÜÀ̳ª ¿¬±â·Î ÀÎÇØ ÃÊÀ½ÆÄ °Ö ¼ö¿ä°¡ ¿µÇâÀ» ¹Þ¾ÒÀ» ¼ö ÀÖ½À´Ï´Ù.

µå¶óÀÌ ÃÊÀ½ÆÄ ±â¼ú¿¡ ´ëÇÑ ¼±È£ : ÀϺΠ¿ëµµ´Â ÃÊÀ½ÆÄ °Ö°ú °°Àº Ä¿ÇøµÁ¦°¡ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ µå¶óÀÌ ÃÊÀ½ÆÄ ±â¼úÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Æ÷ÀÎÆ® ¿Àºê Äɾ ÈÞ´ë¿ë ÃÊÀ½ÆÄ Áø´Ü ÀåÄ¡´Â µå¶óÀÌ ÃÊÀ½ÆÄ ±â¼úÀ» ¼±È£Çϱ⠶§¹®¿¡ ÃÊÀ½ÆÄ °Ö ½ÃÀåÀº ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

Á¦ÇÑµÈ Áö½Ä ¹× ÈÆ·Ã : ÀÇ·á Á¾»çÀÚ´Â ÃÖ»óÀÇ À̹ÌÁö¸¦ ¾ò°í ȯÀÚÀÇ Æí¾ÈÇÔÀ» º¸ÀåÇϱâ À§ÇØ ÃÊÀ½ÆÄ °ÖÀ» »ç¿ëÇÏ´Â °ÍÀÌ ¾ó¸¶³ª Áß¿äÇÑÁö ¾ËÁö ¸øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ È­»ó ó¸® ±â¼úÀ̳ª ÀûÀýÇÑ °Ö µµÆ÷ ÀýÂ÷¿¡ °üÇÑ Æ®·¹ÀÌ´×ÀÌ ºÒÃæºÐÇϱ⠶§¹®¿¡ È­»ó ó¸® °á°ú°¡ ÁÁÁö ¾ÊÀ» °æ¿ì ÃÊÀ½ÆÄ °Ö ½ÃÀå¿¡ ¿µÇâÀÌ ¹ÌÄ¥ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

ȯ°æ Áö¼Ó¼º¿¡ ´ëÇÑ ¿ì·Á : ÃÊÀ½ÆÄ °ÖÀº ÀϹÝÀûÀ¸·Î ÇÑ ¹øÀÇ »ç¿ëÀ¸·Î Æó±âµÇ¹Ç·Î ÀÇ·á Æó±â¹°ÀÌ ¹ß»ýÇÕ´Ï´Ù. Æó±â¹° °ü¸®¿Í ȯ°æÀÇ Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁü¿¡ µû¶ó ģȯ°æ Æ÷Àå ¿É¼ÇÀ̳ª ´ëü Ä¿ÇøµÁ¦¸¦ ã´Â ÀÇ·á½Ã¼³¿¡ µû¶ó ±âÁ¸ ÃÊÀ½ÆÄ °ÖÀÇ ½ÃÀå ¼ö¿ä°¡ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå ¼­¹®

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • ÀüÁ¦ Á¶°Ç

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå °ËÁõµÈ ½ÃÀå Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • ¹ë¸®µ¥À̼Ç
  • 1Â÷ ÀÚ·á
  • µ¥ÀÌÅÍ ¼Ò½º À϶÷

Á¦4Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå : À¯Çüº°

  • °³¿ä
  • ¸ê±Õ
  • ºñ¸ê±Õ

Á¦6Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
  • Ŭ¸®´Ð
  • º´¿ø
  • Áø´Ü¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ °Ö ½ÃÀå °æÀï ±¸µµ

  • °³¿ä
  • °¢»ç ½ÃÀå ·©Å·
  • ÁÖ¿ä °³¹ß Àü·«

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • National Therapy Products
  • Parker Laboratories
  • Sonotech
  • Ultragel Kft
  • ECO-MED
  • Phyto Performance
  • Tele-Paper Malaysia
  • Sonogel Vertriebs
  • Sinan Medical
  • Beinuo BIoTech

Á¦10Àå ºÎ·Ï

  • °ü·Ã Á¶»ç
AJY 25.06.09

Ultrasound Gels Market Size And Forecast

Ultrasound Gels Market size was valued at USD 89.13 Million in 2024 and is projected to reach USD 111.17 Million by 2032, growing at a CAGR of 2.80% from 2026 to 2032.

The market is predicted to develop owing to factors such as the low cost of ultrasound gels, their ease of use, increased demand for ultrasound gels from hospitals, clinics, and diagnostic centers. Additionally, the increased use of ultrasound for illness diagnosis as well as identification of complications associated with a disease fueling the market growth. The Global Ultrasound Gels Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Ultrasound Gels Market Drivers

The market drivers for the Ultrasound Gels Market can be influenced by various factors. These may include:

Growing Prevalence of Chronic Diseases: As chronic diseases like cancer, musculoskeletal disorders, and cardiovascular disorders become more common, there is an increasing need for diagnostic imaging tests like ultrasounds. Because they enable precise diagnosis and excellent imaging, ultrasound gels are critical to the growth of the industry.

Rapid Growth in the Healthcare Sector: The need for medical imaging services is being driven by the healthcare sector's rapid expansion, which is being propelled by factors like urbanisation, ageing demographics, and population growth. The need for ultrasound gels is fueled by the widespread usage of ultrasonography in a variety of healthcare settings, such as clinics, hospitals, diagnostic centres, and ambulatory care facilities.

Developments in Ultrasound Technology: The demand for ultrasound operations is being driven by the ongoing development of ultrasonic technology, which includes the creation of portable devices, high-resolution imaging systems, and 3D/4D imaging capabilities. High-quality ultrasound gels are necessary in light of these technical improvements in order to maximise imaging quality and improve diagnostic precision.

Increasing Use of Point-of-Care Ultrasound (POCUS) Technology: The need for ultrasound gels is being driven by the growing use of point-of-care ultrasound (POCUS) in a number of medical specialties, such as musculoskeletal imaging, emergency medicine, critical care, and obstetrics. For quick and precise imaging during POCUS treatments, portable and convenient ultrasound gels are needed.

Growing Uses in Women's Health: Ultrasound is frequently employed in obstetrics, gynaecology, and breast imaging, among other imaging-related fields, for women's health. The increasing need for ultrasound gels in women's healthcare settings can be attributed to the expanding emphasis on prenatal care, early identification of gynaecological diseases, and breast cancer screening.

Technological Advancements in Gel Formulations: Producers are always coming out with new and improved ultrasound gel formulations that include characteristics like increased conductivity, bacteriostaticity, and hypoallergenicity. These developments boost ultrasound imaging quality, lessen the chance of skin irritation, and increase patient comfort-all of which contribute to the market's expansion.

A Growing Emphasis on Patient Safety and Infection Control: In the wake of the COVID-19 epidemic, healthcare facilities are paying more attention to patient safety and infection control. Market expansion is being driven by the strong demand for sterile ultrasonic gels that meet the strict regulatory requirements for medical devices.

Growing Preference for Non-Invasive Diagnostic techniques: Because non-invasive diagnostic techniques are safe, convenient, and economical, both patients and healthcare professionals are choosing them more and more. The demand for ultrasonic gels is fueled by the fact that ultrasound imaging is a preferred modality for diagnostic imaging due to its non-invasive nature and lack of ionising radiation.

Growing Senior Population: As people age, they become more vulnerable to age-related illnesses and chronic disorders, which calls for diagnostic imaging services. The demand for ultrasonography procedures and ultrasonography gels is rising in tandem with the world's ageing population.

Growing Healthcare Expenditure: The development of healthcare infrastructure, government health programmes, and the expansion of insurance coverage are all contributing to the growth of the healthcare sector as a whole. The need for ultrasound gels is fueled in part by this rise in healthcare spending.

Global Ultrasound Gels Market Restraints

Several factors can act as restraints or challenges for the Ultrasound Gels Market. These may include:

Availability of Substitutes: Although ultrasound gels are frequently employed in ultrasound imaging treatments, there are commercially available lotions and creams as well as alternative coupling agents including water and saline solution. The commercial expansion of ultrasonic gels may be restricted by the presence of alternatives, especially in environments with limited resources.

High Cost of Specialised Formulations: Compared to regular gels, some specialised ultrasonic gel formulations, including sterile or hypoallergenic gels, might be more costly. These speciality formulations are more expensive, which can discourage medical facilities from using them-particularly in areas where funding for healthcare is scarce.

Issues with Skin Sensitivity and Irritation: Some people, especially those with allergies or sensitive skin, may have skin sensitivity or irritation when using ultrasonic gels. For patients with skin sensitivity, healthcare practitioners might need to think about different coupling agents or formulations, which could restrict the market for conventional ultrasound gels.

Regulatory Compliance and Quality Standards: Since ultrasound gels are considered medical devices, they must adhere to different regulatory frameworks and quality standards across different geographical areas. Manufacturers may find it difficult to comply with laws like Good Manufacturing Practices (GMP) and product quality requirements, which can create obstacles to entering and growing new markets.

Issues with Storage and Shelf Life: Ultrasound gels require particular handling during storage, such as maintaining a consistent temperature and guarding against contamination. The low shelf life of ultrasound gels might pose issues for healthcare facilities in terms of inventory management, product freshness, and waste reduction.

Fragmented industry Landscape: There are a lot of manufacturers, suppliers, and distributors in the ultrasonic gels industry, which leads to a fragmented market landscape. Strong rivalry between market participants may result in pressure on prices, narrowed profit margins, and less product differentiation, all of which would impede market expansion.

The COVID-19 Pandemic's effects: Global healthcare systems have been rocked by the COVID-19 pandemic, which has caused changes in patient management techniques, budget allocation, and healthcare priorities. The demand for ultrasound gels may have been impacted by the cancellation or postponement of elective operations, such as non-urgent ultrasound imaging, during the pandemic.

Preference for Dry Ultrasonic Technologies: In some applications, dry ultrasound technologies are becoming more and more popular as they do away with the necessity for coupling agents like ultrasound gels. The market for ultrasound gels may face difficulties due to point-of-care and portable ultrasound devices' predilection for dry ultrasound technologies.

Limited Knowledge and Training: It's possible that medical professionals are unaware of how crucial it is to use ultrasound gels in order to get the best possible images and ensure patient comfort. The market for ultrasound gels may be impacted by subpar imaging results from inadequate training on ultrasonic imaging techniques and appropriate gel application procedures.

Environmental Sustainability Concerns: Medical waste is generated because ultrasound gels are usually disposed of after a single use. The market demand for conventional ultrasound gels may be impacted by healthcare facilities looking for eco-friendly packaging options or alternative coupling agents in response to growing concerns about waste management and environmental sustainability.

Global Ultrasound Gels Market Segmentation Analysis

The Global Ultrasound Gels Market is segmented on the basis of Type, End-User, And Geography.

Ultrasound Gels Market, By Type

  • Sterile
  • Non-sterile

Based on Type, The market is bifurcated into Sterile and Non-sterile. Non-sterile gels account for a higher share of the market owing to the increasing number of external probe ultrasound operations to assess the kidney, uterus, heart, gall bladder, liver, and reproductive organs increases.

Ultrasound Gels Market, By End-User

  • Clinics
  • Hospital
  • Diagnostic Centers
  • Others

Based on End-User, The market is bifurcated into Clinics, Hospital, Diagnostic Centers, and Others. In 2019, the hospital category had the highest revenue share, and it is expected to grow at a high CAGR over the next few years. The rising frequency of emergency room visits for disorders including acute abdominal pain, chest discomfort, and vascular difficulties, for which ultrasound is the primary diagnostic tool, is likely to boost demand for ultrasound gels.

Ultrasound Gels Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, The Global Ultrasound Gels Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Owing to good healthcare infrastructure, increased prevalence of chronic diseases, and scope for innovation, North America is likely to lead the global Ultrasound Gels Market throughout the forecast period. Attributed to the growing public awareness, government initiatives toward healthcare, and rising investment, Asia-Pacific is predicted to have a higher CAGR over the forecast period.

Key Players

The "Global Ultrasound Gels Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as National Therapy Products, Parker Laboratories, Sonotech, Ultragel Kft, ECO-MED, Phyto Performance, Tele-Paper Malaysia, Sonogel Vertriebs, Sinan Medical, and Beinuo Biotech. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ULTRASOUND GELS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL ULTRASOUND GELS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL ULTRASOUND GELS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Sterile
  • 5.3 Non-sterile

6 GLOBAL ULTRASOUND GELS MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Clinics
  • 6.3 Hospital
  • 6.4 Diagnostic Centers
  • 6.5 Others

7 GLOBAL ULTRASOUND GELS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL ULTRASOUND GELS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 National Therapy Products
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Parker Laboratories
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Sonotech
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Ultragel Kft
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 ECO-MED
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Phyto Performance
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Tele-Paper Malaysia
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Sonogel Vertriebs
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sinan Medical
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Beinuo Biotech
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦